Evidence map›Paper›PMID 37566088›Full record

ArticleCells2023

Simona Rossi, Michela Di Salvio, Marilisa Balì, Assia De Simone, Savina Apolloni, Nadia D'Ambrosi, Ivan Arisi, Francesca Cipressa, Mauro Cozzolino, Gianluca Cestra

Open access · goldAbstract read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Decoding Nucleotide Repeat Expansion Diseases: Novel Insights fromInternational journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Simona RossiInstitute of Translational Pharmacology (IFT), National Research Council (CNR), 00133 Rome, Italy.ORCID 0000-0001-5038-0767
Michela Di SalvioInstitute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), 00185 Rome, Italy.
Marilisa BalìDepartment of Biology and Biotechnology, University of Rome "La Sapienza", 00185 Rome, Italy.
Assia De SimoneDepartment of Biology and Biotechnology, University of Rome "La Sapienza", 00185 Rome, Italy.
Savina ApolloniDepartment of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0002-5782-1665
Nadia D'AmbrosiFondazione Santa Lucia IRCCS, c/o CERC, 00143 Rome, Italy.ORCID 0000-0002-6646-7653
Ivan ArisiInstitute of Translational Pharmacology (IFT), National Research Council (CNR), 00133 Rome, Italy.
Francesca CipressaDepartment of Ecological and Biological Science, University of Tuscia, 01100 Viterbo, Italy.ORCID 0000-0002-9919-5295
Mauro CozzolinoInstitute of Translational Pharmacology (IFT), National Research Council (CNR), 00133 Rome, Italy.ORCID 0000-0003-0342-8961
Gianluca CestraFondazione Santa Lucia IRCCS, c/o CERC, 00143 Rome, Italy.
Istituto di Farmacologia Traslazionale · ITInstitute of Molecular Biology and Pathology · ITSapienza University of Rome · ITUniversity of Rome Tor Vergata · ITUniversità degli Studi della Tuscia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Compelling evidence indicates that defects in nucleocytoplasmic transport contribute to the pathogenesis of amyotrophic lateral sclerosis (ALS). In particular, hexanucleotide (G4C2) repeat expansions in

Indexed as

Amyotrophic Lateral SclerosisC9orf72 ProteinGTPase-Activating ProteinsADP-Ribosylation Factor 1AnimalsDrosophilaHumansMiceRNARNA, MessengerADP-Ribosylation Factor 1ARFGAP1 protein, humanC9orf72 ProteinC9orf72 protein, humanGTPase-Activating ProteinsRNARNA, Messengeramyotrophic lateral sclerosisArfGAP-1C9orf72Drosophila melanogasterGolgi-to-ER trafficking

Identifiers

PMID37566088
PMCPMC10416972
OpenAlexW4385602830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.